NH99 - CAS号查询

a-Conotoxin Pn IA (reduced) (9CI);
L-Cysteinamide,glycyl-L-cysteinyl-L-cysteinyl-L-seryl-L-leucyl-L-prolyl-L-prolyl-L-cysteinyl-L-alanyl-L-alanyl-L-asparaginyl-L-asparaginyl-L-prolyl-L-a-aspartyl-O-sulfo-L-tyrosyl-

C65H99N19O25S5

详情

供应商

144572-46-3

Bacitracin D3 (9CI);
BacitracinF,1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucine]-3-L-valine-6-L-valine-;
1,4,7,10,13,16,19-Heptaazacyclopentacosane, cyclic peptide deriv.;
BacitracinC1a;
L-Asparagine,N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucyl-D-a-glutamyl-L-valyl-L-lysyl-D-ornithyl-L-valyl-D-phenylalanyl-L-histidyl-D-a-aspartyl-, cyclic (10®
4)-peptide,[4R-[2(1S*,2S*),4R*]]-

Bacitracin C1 (9CI);
L-Asparagine,N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucyl-D-a-glutamyl-L-valyl-L-lysyl-D-ornithyl-L-valyl-D-phenylalanyl-L-histidyl-D-a-aspartyl-, cyclic (10®
4)-peptide

Hexacosanamide,N-[(1S,2S,3R)-1-[(a-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-;
Hexacosanamide,N-[1-[(a-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-,[1S-(1R*,2R*,3S*)]-;
KRN 7000

Hexacosanamide,N-[(1S,2S,3R)-1-[(b-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-;
Hexacosanamide,N-[1-[(b-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-,[1S-(1R*,2R*,3S*)]-;
AGL 583;
Agelasphin 583

Myotropin I (Locustamigratoria male accessory reproductive organ) (9CI);
Allatotropin(Manduca sexta), 6-L-alanine-7-L-leucine-8-L-serine-;
L-Phenylalaninamide,glycyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-valyl-L-alanyl-L-leucyl-L-seryl-L-threonyl-L-alanyl-L-arginylglycyl-;
Lom-AG-MT-I;
Myotropin (Leptinotarsa decemlineata brain)

Pedal peptide (Aplysiacalifornica) (9CI);
L-Alanine,L-prolyl-L-leucyl-L-a-aspartyl-L-seryl-L-valyl-L-tyrosylglycyl-L-threonyl-L-histidylglycyl-L-methionyl-L-serylglycyl-L-phenylalanyl-

Pentanamide,2,5-bis[(3-aminopropyl)amino]-N,N-dioctadecyl-;
dioctadecylamidospermine

Substance P-relatedpeptide (Carassius auratus langsdorfii) (9CI);
Carassiussubstance P;
L-Methioninamide, L-lysyl-L-prolyl-L-arginyl-L-prolyl-L-histidyl-L-glutaminyl-L-phenylalanyl-L-isoleucylglycyl-L-leucyl-

Substance P,11-L-methionine-, methyl ester;
Substance Pmethyl ester;
[Met-OMe11]-Substance P

1-11-Neurotensin(cattle) (9CI);
Neurotensin(ox), 12-de-L-isoleucine-13-de-L-leucine-;
(1-11)Neurotensin;
197: PN:WO0061194 SEQID: 197 claimed sequence;
217: PN: EP1170021 SEQID: 219 claimedprotein;
Neurotensin(1-11);
Ox neurotensin(1-11)

1,2,3,4-Butanetetracarboxylicacid, 1-hexadecyl 2,3,4-tris(1,2,2,6,6-pentamethyl-4-piperidinyl) ester;
1-hexadecyl 2,3,4-tris(1,2,2,6,6-pentamethyl-4-piperidyl) butane-1,2,3,4-tetracarboxylate

9-Octadecenoic acid(9Z)-, neodymium(3+) salt (9CI);
9-Octadecenoicacid (Z)-, neodymium(3+) salt;
Neodymium oleate

(1-腺嘌呤乙酰基-D-精氨酸0,羟脯氨酸3,-(2-二噻吩基)丙氨酸5,8,D-苯丙氨酸7)-舒缓激肽

(1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ;
N-ADAMANTANEACETYL-DARG-ARG-PRO-HYP-GLY-THI-SER-DPHE-THI-ARG;
[N-ADMANTANEACETYL-DARG0-HYP3,THI5,8,DPHE7] BRADYKININ;
N-ALPHA-ADAMANTANEACETYL-D-ARG-ARG-PRO-HYDROXY-PRO-GLY-BETA-[2-THIENYL]ALA-SER-D-PHE-BETA-[2-THIENYL]ALA-ARG;
N-ALPHA-ADAMANTANEACETYL-D-ARG-[HYP3,THI5,8,D-PHE7]-BRADYKININ;
(1-ADAMANTANEACETYL-D-ARG0,HYP3,3-ALA(2-THIENYL)5,8,D-PHE7)-BRADYKININ;
(1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ;
1-ADAMANTANEACETYL-D-ARG-ARG-PRO-HYP-GLY-3-ALA(2-THIENYL)-SER-D-PHE-3-ALA(2-THIENYL)-ARG-OH;
1-ADAMANTANEACETYL-D-ARG-ARG-PRO-HYP-GLY-BETA-(2-THIENYL)-ALA-SER-D-PHE-BETA-(2-THIENYL)-ALA-ARG

CART (62-76) (HUMAN, RAT)

CART (62-76) (HUMAN, RAT);
TYR-GLY-GLN-VAL-PRO-MET-CYS-ASP-ALA-GLY-GLU-GLN-CYS-ALA-VAL;
COCAINE-AND AMPHETAMINE-REGULATED TRANSCRIPT (62-76) (HUMAN, RAT);
COCAINE-AND AMPHETAMINE-REGULATED TRANSCRIPT (62-76), RAT, HUMAN;
CART (62-76) (HUMAN, RAT);
CART (62-76), RAT, HUMAN;
H-TYR-GLY-GLN-VAL-PRO-MET-CYS-ASP-ALA-GLY-GLU-GLN-CYS-ALA-VAL-OH

COMPSTATIN

Compstatin;
Compstatin;
H-Ile-Cys-Val-Val-Gln-Asp-Trp-Gly-His-His-Arg-Cys-Thr-NH2, (Disulfide bond)

GLY-GLN-GLN-HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL

FIBRINOGEN GAMMA-CHAIN (397-411);
H-GLY-GLN-GLN-HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL-OH;
FIBRINOGEN RELATED PEPTIDE;
FIBRINOGEN GAMMA-CHAIN (397-411);
GLY-GLN-GLN-HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL;
GQQHHLGGAKQAGDV

[2-[bis(2-hydroxypropyl)amino]ethyl]bis(2-hydroxypropyl)(methyl)ammonium methyl sulphate, dioleate (ester);
[2-[bis(2-hydroxypropyl)amino]ethyl]bis(2-hydroxypropyl)(methyl)ammonium methyl sulphate, dioleate (ester);
1-Propanaminium, N-2-bis(2-hydroxypropyl)aminoethyl-2-hydroxy-N-(2-hydroxypropyl)-N-methyl-, di-(9Z)-9-octadecenoate (ester), methyl sulfate (salt);
(2-(Bis(2-hydroxypropyl)amino)ethyl)bis(2-hydroxypropyl)(methyl)ammonium methyl sulphate, dioleate (ester);
1-Propanaminium, N-(2-(bis(2-hydroxypropyl)amino)ethyl)-2-hydroxy-N-(2-hydroxypropyl)-N-methyl-, di-(9Z)-9-octadecenoate (ester), methyl sulfate (1:1);
Einecs 265-339-0

无

C51H99N2O6.CH3O4S

详情

供应商

化工产品